Comparison

Matuzumab European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 5mg
Item no. TMO-T9922-5mg
Targets EGFR
CASRN 339186-68-4
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.
Shipping
cool pack
Storage
-20°
Pathway
Angiogenesis|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors
Target
EGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Delivery expected until 5/9/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?